Related references
Note: Only part of the references are listed.Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Cardiovascular Disease and Cancer: Is There Increasing Overlap?
Logan Vincent et al.
CURRENT ONCOLOGY REPORTS (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study
Pradhum Ram et al.
HEART FAILURE REVIEWS (2019)
Antineoplastic-related cardiovascular toxicity: A systematic review and meta-analysis in Asia
Siew Lian Leong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis
Pierre O'Brien et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Updates in Anthracycline-Mediated Cardiotoxicity
Canan G. Nebigil et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
Ana Filipa Reis-Mendes et al.
CURRENT DRUG METABOLISM (2016)
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer
Stefania Mantarro et al.
INTERNAL AND EMERGENCY MEDICINE (2016)
SERIAL MONITORING OF LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
Polyvios Demetriades et al.
HEART (2016)
Detection of cardiotoxicity in patients with breast cancer treated with chemotherapy
A Tünnemann-Tarr et al.
ULTRASCHALL IN DER MEDIZIN (2016)
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis
Norihiro Yamaguchi et al.
EUROPEAN JOURNAL OF CANCER (2015)
Effectiveness and Complications of Anthracycline and Taxane in the Therapy of Breast Cancer: A Meta-analysis
Qing-jing Feng et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines
Shailendra Verma et al.
CANCER TREATMENT REVIEWS (2008)